Corteva Q4 FY25 earnings call CTVA

Corteva reached a comprehensive resolution with Bayer, solidifying its seed freedom to operate and resolving all outstanding litigation. This agreement is expected to generate approximately $1 billion of aggregate earnings upside for Corteva over the next decade across its corn, cotton, and canola portfolios. It accelerates royalty neutrality to 2026, two years ahead of prior expectations, and allows for the introduction of existing triple-stack corn technologies for licensing as early as 2027, a five-year acceleration. The resolution also facilitates the introduction of Corteva's third-generation aboveground trait platform in North America corn by the end of the decade, two years earlier than planned, and enables entry into the US cotton licensing market.

Corteva concluded 2025 with strong financial results, achieving low single-digit top-line growth and low double-digit operating EBITDA improvement, leading to over 200 basis points of margin expansion to exceed 22%. This performance was attributed to growing demand for technology, commercial team execution, and disciplined operational efficiency across both Seed and Crop Protection businesses. The company also delivered record free cash flow of $2.9 billion, a $1.2 billion improvement year-over-year, driven by increased EBITDA, lower cash taxes, and working capital discipline.

Corteva reiterated its preliminary 2026 operating EBITDA midpoint of $4.1 billion, representing 7% growth over the prior year. This estimate includes significant momentum from the Seed Licensing business, mid-single-digit volume growth in Crop Protection driven by new products and biologicals, and approximately $200 million in productivity benefits across both businesses. The company anticipates a $120 million improvement in net royalty expense and a $75 million currency tailwind on operating EBITDA, partially offset by an $80 million headwind from tariffs and $50 million in net dissynergies related to the separation.

The Seed business performed well in 2025, achieving organic growth in every region and market share gains in both corn and soybeans. It delivered approximately $340 million in net cost improvements and $90 million in royalty improvement, reflecting a growing position in North America corn and progress in soybean licensing in Brazil. The company expects to cross double-digit trade penetration for Conkesta E3 soybeans in Brazil in 2026, with significant momentum in its licensing model.

Corteva's Crop Protection business delivered top and bottom-line growth and margin expansion in 2025, despite less than ideal market conditions and competitive pricing dynamics in some regions. The business generated over $300 million in productivity and cost benefits, improving its resilience. For 2026, the company expects modest growth in the overall Crop Protection market, driven by demand for new products and biologicals, which are anticipated to outperform the rest of the portfolio.

Corteva remains on track for a second-half separation, most likely in Q4 2026. Key milestones include an announcement on the new Corteva CEO in H1, launching the SpinCo name and brand identity, and filing the initial Form 10 with the SEC. The second half will focus on going effective on the Form 10, announcing Board appointments, and receiving final capital structure approvals. The separation aims to sharpen focus, accelerate innovation, and unlock value for shareholders, with Investor Day events planned for mid-September.

Corteva highlighted significant global progress in regulatory support for gene editing, particularly in Europe with an expected formal adoption of a new framework in H1 2026. The company is developing a gene-edited fungal disease-resistant corn hybrid, referred to as a 'disease super locus,' which shows promising results in test plots and is expected to be commercialized within one to two years after regulatory approvals. Additionally, the fungicide 'Visa,' targeting Asian soybean rust, is anticipated to launch in the latter part of 2026, further augmenting the differentiated Crop Protection portfolio.